About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Medical Oncology
›
top-articles
Department of Medical Oncology
945
(top 1%)
papers
45.3K
(top 0.1%)
citations
91
(top 0.1%)
h
-index
172
(top 0.1%)
g
-index
997
all documents
47.9K
doc citations
4.6K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy
2016
4,701
2
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy
2012
3,122
3
Cell Death Independent of Caspases: A Review
Clinical Cancer Research
2005
792
4
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Cancer Cell
2015
700
5
Langerin is a natural barrier to HIV-1 transmission by Langerhans cells
Nature Medicine
2007
563
6
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Angiogenesis
2017
482
7
Levels of hypoxia-inducible factor-1? independently predict prognosis in patients with lymph node negative breast carcinoma
Cancer
2003
472
8
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Blood
2016
429
9
Consensus guidelines for the use and interpretation of angiogenesis assays
Angiogenesis
2018
429
10
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Drug Resistance Updates
2011
415
11
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Angiogenesis
2010
408
12
Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
Cancer Cell
2012
307
13
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
Biochimica Et Biophysica Acta - Molecular Basis of Disease
2002
304
14
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
Drug Resistance Updates
2002
297
15
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Clinical Cancer Research
2011
275
16
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
Blood
2017
262
17
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
PLoS ONE
2010
261
18
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
Oncotarget
2016
248
19
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
Cell Reports
2018
245
20
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer
Human Brain Mapping
2011
243
21
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Cancer Cell
2017
235
22
Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Journal of Medicinal Chemistry
2011
229
23
Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling
Journal of Cell Biology
2018
227
24
In vivo
anti-tumor activity of the organometallic ruthenium(
ii
)-arene complex [Ru(η
6
-
p
-cymene)Cl
2
(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
Chemical Science
2014
224
25
Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset
Journal of Proteomics
2014
222
26
Cathepsin B Mediates Caspase-Independent Cell Death Induced by Microtubule Stabilizing Agents in Non-Small Cell Lung Cancer Cells
Cancer Research
2004
204
27
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
Annals of Oncology
2004
196
28
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
Drug Resistance Updates
2009
196
29
Discovery of
N
-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells
Journal of Medicinal Chemistry
2011
195
30
Analysis of Drug Interactions
Methods in Molecular Biology
2011
189
31
Tyrosine kinase inhibitors: Multi-targeted or single-targeted?
World Journal of Clinical Oncology
2011
184
32
Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies
International Journal of Cancer
2005
173
33
In vivo Induction of Resistance to Gemcitabine Results in Increased Expression of Ribonucleotide Reductase Subunit M1 as the Major Determinant
Cancer Research
2005
170
34
Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response
Clinical Cancer Research
2008
163
35
Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
Cell Death and Differentiation
2013
163
36
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma
Cancer Immunology Research
2015
159
37
Composition of the type
VII
secretion system membrane complex
Molecular Microbiology
2012
155
38
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
Critical Reviews in Oncology/Hematology
2012
154
39
Essential Role of the ESX-5 Secretion System in Outer Membrane Permeability of Pathogenic Mycobacteria
PLoS Genetics
2015
154
40
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
Frontiers in Immunology
2017
154
41
TRAIL and cancer therapy
Cancer Letters
2008
153
42
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Frontiers in Pharmacology
2016
152
43
Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
Clinical Cancer Research
2011
150
44
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression
Clinical Cancer Research
2017
150
45
Proteomic Profiling of Mycobacterium tuberculosis Identifies Nutrient-starvation-responsive Toxin–antitoxin Systems
Molecular and Cellular Proteomics
2013
148
46
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
Annals of Oncology
2009
147
47
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
British Journal of Cancer
2010
146
48
Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity
Molecular Cancer Therapeutics
2002
145
49
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
Oncogene
2013
144
50
MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
Gastroenterology
2014
141
site/software ©
exaly
; All materials licenced under
CC by-SA
.